Bioprocess BD Hunter - Capital Equipment & Key Accounts

VERDOT Biotechnologies; Raleigh (NC); Híbrido; USD 175.000 - 230.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Health insurance

Dental insurance

Vision insurance

401(k)

Descripción de la vacante

VERDOT Biotechnologies is seeking a high-energy sales professional to own new business and account growth across the Mid-Atlantic and Southeast bioprocess markets. You will open doors with PD, MSAT, engineering and sourcing teams, and close capital equipment deals in a hunter role with real technical depth.

In your first year you’ll take over established Mid-Atlantic accounts while building pipeline for large North Carolina manufacturing sites, traveling roughly 50% to visit customers and

Formación

• 5+ years of B2B sales or business development in bioprocessing or life sciences equipment.
• Track record closing capital equipment deals in $100K–$2M+.
• Knowledge of downstream processing and bioprocessing markets.
• Existing network in Mid-Atlantic/Southeast biopharma/biotech/CDMO.

Responsabilidades

• Own new business and account growth across the Mid-Atlantic and Southeast.
• Open doors with PD, MSAT, engineering and sourcing teams.
• Close capital equipment deals and manage full sales cycle.
• Represent Verdot at trade shows and regional events.
• Maintain HubSpot with accounts, contacts, meetings and deals.

Conocimientos

B2B sales

Bioprocessing knowledge

Capital equipment

Territory development

Stakeholder management

Educación

Bachelor's degree in life sciences, engineering or business

Descripción del empleo

VERDOT Biotechnologies is seeking a high-energy sales professional to own new business and account growth across the Mid-Atlantic and Southeast bioprocess markets. You will open doors with PD, MSAT, engineering and sourcing teams, and close capital equipment deals in a hunter role with real technical depth.

In your first year you’ll take over established Mid-Atlantic accounts while building pipeline for large North Carolina manufacturing sites, traveling roughly 50% to visit customers and